Correlation Between InMed Pharmaceuticals and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both InMed Pharmaceuticals and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMed Pharmaceuticals and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InMed Pharmaceuticals and Cns Pharmaceuticals, you can compare the effects of market volatilities on InMed Pharmaceuticals and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMed Pharmaceuticals with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMed Pharmaceuticals and Cns Pharmaceuticals.
Diversification Opportunities for InMed Pharmaceuticals and Cns Pharmaceuticals
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between InMed and Cns is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and InMed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMed Pharmaceuticals are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of InMed Pharmaceuticals i.e., InMed Pharmaceuticals and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between InMed Pharmaceuticals and Cns Pharmaceuticals
Considering the 90-day investment horizon InMed Pharmaceuticals is expected to generate 1.23 times more return on investment than Cns Pharmaceuticals. However, InMed Pharmaceuticals is 1.23 times more volatile than Cns Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 276.00 in InMed Pharmaceuticals on August 16, 2025 and sell it today you would lose (95.00) from holding InMed Pharmaceuticals or give up 34.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
InMed Pharmaceuticals vs. Cns Pharmaceuticals
Performance |
| Timeline |
| InMed Pharmaceuticals |
| Cns Pharmaceuticals |
InMed Pharmaceuticals and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with InMed Pharmaceuticals and Cns Pharmaceuticals
The main advantage of trading using opposite InMed Pharmaceuticals and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMed Pharmaceuticals position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| InMed Pharmaceuticals vs. Biodexa Pharmaceticals | InMed Pharmaceuticals vs. Genprex | InMed Pharmaceuticals vs. Biovie Inc | InMed Pharmaceuticals vs. Galmed Pharmaceuticals |
| Cns Pharmaceuticals vs. Windtree Therapeutics | Cns Pharmaceuticals vs. Pasithea Therapeutics Corp | Cns Pharmaceuticals vs. Soligenix | Cns Pharmaceuticals vs. Oragenics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |